AZAPLAST 100MG INJECTION

About AZAPLAST 100MG INJECTION

Azaplast 100MG Injection contains azacitidine 100mg. It switches back on genes that keep blood cells maturing normally and kills abnormal marrow cells, which is why it is classed as a hypomethylating agent (chemotherapy). Specialists use it for myelodysplastic syndromes (MDS), acute myeloid leukaemia (AML) and chronic myelomonocytic leukaemia; tablets are for AML maintenance. During treatment expect regular checks such as blood counts before each cycle. Made by RPG Life Sciences; pack size 1 vial. MRP Rs 1,279 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.